ArticleESMO gastrointestinal oncology2026
NALIRIFOX in Japanese treatment-naïve patients with metastatic pancreatic adenocarcinoma: results from an open-label, phase II study.
M Ueno et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.